First-line immune checkpoint inhibitor-based combinations in unresectable hepatocellular carcinoma: current management and future challenges
-
- Alessandro Rizzo
- Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, Italy
-
- Angela Dalia Ricci
- Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, Italy
-
- Gennaro Gadaleta-Caldarola
- Department of Medical Oncology, Medical Oncology Unit, “Mons. R. Dimiccoli” Hospital, Barletta (BT), ASL BT, Italy
-
- Giovanni Brandi
- Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, Italy
収録刊行物
-
- Expert Review of Gastroenterology & Hepatology
-
Expert Review of Gastroenterology & Hepatology 15 (11), 1245-1251, 2021-08-31
Informa UK Limited